10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:   March 31, 2016

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________.

Commission file number: 000-50053

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)

NEVADA	87-0535207
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA	89005
(Address of principal executive offices)	(Zip Code)

(702) 293-1930

(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨      Accelerated filer  ¨      Non-accelerated filer  ¨      Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No  x

The number of shares outstanding of Registrant’s Common Stock as of May 9, 2016: 42,175,287

TABLE OF CONTENTS

		Page
PART I
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operation	13
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21
Item 4.	Controls and Procedures	21
PART II
Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 3.	Defaults Upon Senior Securities	22
Item 4.	Mine Safety Disclosures	22
Item 5.	Other Information	22
Item 6.	Exhibits	22
SIGNATURES		23

PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

AMERITYRE CORPORATION

Balance Sheets

	March 31, 2016			June 30, 2015
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	103,319		$	455,717
Accounts receivable - net		486,264			314,054
Accounts receivable - related party		-			6,312
Inventory - net		634,991			661,129
Prepaid and other current assets		66,199			27,860
Total Current Assets		1,290,773			1,465,072
PROPERTY AND EQUIPMENT
Leasehold improvements		153,543			153,543
Molds and models		577,549			572,894
Equipment		2,960,246			2,937,922
Furniture and fixtures		74,921			74,921
Software		305,924			305,924
Less - accumulated depreciation		(3,831,584	)		(3,735,744	)
Total Property and Equipment		240,599			309,460
OTHER ASSETS
Patents and trademarks - net		182,212			202,710
Non-current inventory		187,380			186,560
Deposits		11,000			11,000
Total Other Assets		380,592			400,270
TOTAL ASSETS	$	1,911,964		$	2,174,802
LIABILITIES AND STOCKHOLDER'S EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	452,052		$	438,680
Current portion of long-term debt		12,005			13,608
Current portion of lease liability		5,938			-
Total Current Liabilities		469,995			452,288
Long-term debt		53,840			53,840
Long-term lease liability		10,077			-
Total Long-Term Liabilities		63,917			53,840
TOTAL LIABILITIES		533,912			506,128
STOCKHOLDERS' EQUITY
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively		2,000			2,000
Common stock: 75,000,000 shares authorized of $0.001 par value, 42,025,287 and 41,441,620 shares Issued and outstanding, respectively		42,025			41,570
Additional paid-in capital		62,567,140			62,515,856
Stock payable		4,500			-
Accumulated deficit		(61,237,613	)		(60,890,752	)
Total Stockholders' Equity		1,378,052			1,668,674
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	1,911,964		$	2,174,802

The accompanying notes are an integral part of these financial statements.

3

AMERITYRE CORPORATION

Statements of Operations

(Unaudited)

	For the Three Months Ended March 31,						For the Nine Months Ended March 31,
	2016			2015			2016			2015
NET SALES	$	936,612		$	1,190,841		$	2,865,433		$	3,571,901
COST OF GOODS SOLD		618,366			851,688			2,081,813			2,688,553
GROSS PROFIT		318,246			339,153			783,620			883,348
EXPENSES
Research and development		56,839			58,146			166,406			155,636
Sales and marketing		53,639			140,573			219,898			426,778
General and administrative		172,270			189,936			666,910			638,231
Total Expenses		282,748			388,655			1,053,214			1,220,645
INCOME (LOSS) FROM OPERATIONS		35,498			(49,502	)		(269,594	)		(337,297	)
OTHER (EXPENSE)/INCOME
Interest expense		(870	)		-			(2,404	)		-
Interest income		28			100			137			466
Total Other (Expense)/Income		(842	)		100			(2,267	)		466
NET INCOME (LOSS)		34,656			(49,402	)		(271,861	)		(336,831	)
Preferred Stock Dividend		(25,000	)		(25,000	)		(75,000	)		(75,000	)
NET INCOME (LOSS)ATTRIBUTABLE TO COMMON SHAREHOLDERS	$	9,656		$	(74,402	)	$	(346,861	)	$	(411,831	)
BASIC INCOME (LOSS)PER SHARE	$	0.00		$	(0.00	)	$	(0.01	)	$	(0.01	)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		41,951,935			41,524,135			41,770,978			41,469,326
DILUTED INCOME (LOSS)PER SHARE	$	0.00		$	(0.00	)	$	(0.01	)	$	(0.01	)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		41,951,935			41,524,135			41,770,978			41,469,326

The accompanying notes are an integral part of these financial statements.

4

AMERITYRE CORPORATION

Statements of Cash Flows

(Unaudited)

	For the Nine Months Ended March 31,
	2016			2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(271,861	)	$	(336,831	)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization expense		116,338			146,930
Change in allowance for bad debt recovery		(289	)		(8,066	)
Stock paid for services		-			5,147
Stock based compensation related to consultant, employee and director options		56,238			18,638
Changes in operating assets and liabilities:
Accounts receivable		(165,609	)		(121,652	)
Inventory and inventory reserve		25,318			156,426
Prepaid and other current assets		(38,339	)		(81,906	)
Accounts payable and accrued expenses		5,731			(103,385	)
Net Cash Used by Operating Activities		(272,473	)		(324,699	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		-			(45,786	)
Net Cash Used by Investing Activities		-			(45,786	)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on lease liability		(3,322	)		-
Payments on notes payable		(1,603	)		(2,084	)
Preferred stock issuance costs		-			(188	)
Preferred stock dividends		(75,000	)		(75,000	)
Net Cash Used by Financing Activities		(79,925	)		(77,272	)
NET DECREASE IN CASH		(352,398	)		(447,757	)
CASH AT BEGINNING OF PERIOD		455,717			728,585
CASH AT END OF PERIOD	$	103,319		$	280,828

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES
Interest paid	$	2,404	$	-
Income taxes paid	$	-	$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES
Capitalized lease	$	19,337	$	-
Reclassification of accounts receivable – related party to accounts receivable	$	6,312	$	-
Equipment purchase accrued for, not paid in cash	$	7,641	$	-
Reversal of deferred financing costs	$	-	$	31,500

The accompanying notes are an integral part of these financial statements.

5

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K.  Operating results for the nine months ended March 31, 2016 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at March 31, 2015.

Trade Receivables

We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses. As of March 31, 2016 and 2015, the reserve for uncollectible accounts was $-0- and $7,556, respectively.

Stock Based-Compensation Expense

We account for stock-based compensation under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended March 31, 2015 and 2016 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the nine months ended March 31, 2016 and 2015 was $56,238 and $18,638, respectively.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the nine months ended March 31, 2016 and 2015 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation, except for the three months ended March 31, 2016.  For the three months ended March 31, 2016 only warrants and options “in the money” have been included in the dilutive calculation, which resulted in zero additional weighted average shares.  We excluded 4,300,000 and 2,924,000 common stock equivalents for the nine months ended March 31, 2016 and 2015, respectively, because they are anti-dilutive.

6

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Continued

Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities’ processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.

In February 2016, the FASB issued ASU No. 2016-02, "Leases", ("ASU 2016-02") which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2018 with early adoption permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on the Company's financial statements.

In March 2016, the FASB issued ASU No. 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." ASU 2016-09 amends several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period. The Company is currently evaluating the impact of the adoption of ASU 2016-09 on the Company's financial statements.

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board (IASB) to improve financial reporting by creating common revenue recognition guidance for GAAP and International Financial Reporting Standards (IFRS).  In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.” ASU 2016-10 clarifies the implementation guidance on identifying performance obligations. These ASUs apply to all companies that enter into contracts with customers to transfer goods or services. These ASUs are effective for public entities for interim and annual reporting periods beginning after December 15, 2017. Early adoption is permitted, but not before interim and annual reporting periods beginning after December 15, 2016. Entities have the choice to apply these ASUs either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying these standards at the date of initial application and not adjusting comparative information. The Company is currently evaluating the impact of the adoption of ASU 2016-10 on the Company's financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

7

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Continued

Related Party Transactions

Amerityre’s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  As of December 2015, with Mr. Ryan’s exit from our Board of Directors, he was no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.

We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.  In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.  Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced from our Boulder City location.

NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

	March 31, 2016			June 30, 2015
	(Unaudited)
Raw Materials	$	307,388		$	302,910
Finished Goods		631,780			655,714
Inventory reserve		(116,797	)		(110,935	)
Inventory - net	$	822,371			847,689

Our inventory reserve reflects items that were deemed to be slow moving or obsolete based on an analysis of all inventories on hand.

The Company critically reviews all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete, but slow moving, we present these items as non-current inventory, although all inventory is ready and available for sale at any moment. 

8

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 4 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2016:

2016	$	2,188
2017		8,697
2018		8,697
2019		725
2020		-
Total minimum lease payments		20,307
Less:  executory costs		-
Net minimum lease payments		20,307
Less:  amount representing interest		4,292
Present value of net minimum payments	$	16,015

NOTE 5 - STOCK TRANSACTIONS

As of March 31, 2016, the Board of Directors granted the following stock bonus awards:

·   To all non-officer employees of Amerityre on record as of July 22, 2015, a one-time stock bonus award of 5,000 shares of the Company’s restricted common stock per employee, valued at $0.015 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).  As of July 22, 2015 there were 16 non-officer employees at Amerityre resulting in 80,000 shares, which were issued in July 2015.

·   To the officers of Amerityre, 600,000 shares were granted on July 20, 2015 (valued at $0.03) with 75% of the grant allocated to the CEO and 25% of the grant allocated to the CFO.  The shares of stock vest ratably each quarter end during fiscal year 2016 and are payable immediately after the vesting date.  For the nine months ended March 31, 2016 the Company recognized $13,500 of compensation expense for these grants; $4,500 of which is a stock payable.

·   In February 2016,the Board approved 75,000 shares of stock be issued to a senior management employee in connection with his employment agreement, valued at $0.025 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).  These shares were issued in March 2016.

9

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 6 - STOCK OPTIONS AND WARRANTS

General Option Information

On July 6, 2011, the Board of Directors cancelled the “2004 Non-Employee Directors’ Stock Incentive Plan” and approved the "Directors’ 2011 Stock Option and Award Plan”.   Under the 2011 Plan, a total of 3,300,000 shares are authorized for issuance.

The Company also maintained the 2005 Stock Option and Award Plan, which was previously approved by shareholders, for the purpose of granting option awards to its employees and consultants.   This plan had a 10 year life and expired July 2015.

On August 10, 2015, the Board of Directors cancelled the “Directors’ 2011 Stock Option and Award Plan” as all options under this plan had been granted and adopted the “2015 Omnibus Stock Option and Award Plan” which contains provisions for up to 3,000,000 stock options to be granted to employees, consultants and directors.  The 2015 Omnibus Stock Option and Award Plan did not obtain the necessary shareholder approval in the Company’s annual proxy process, resulting in certain U.S. Internal Revenue Service provisions to be ineffective.

Option issuances and vesting during the nine month period ending March 31, 2016

On December 1, 2014, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2015 and expire December 1, 2020.  Year to date expense related to these options is $7,746 as of March 31, 2016. 

On January 21, 2015, 50,000 options were granted to the Company’s Chief Financial Officer as part of her employment offer.  The options have a strike price of $0.10, vest ratably January 21, 2015 to December 1, 2015 and expire December 1, 2018.  Year to date expense related to these options is $840 as of March 31, 2016.

In the October 2015 Board meeting, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2015.  The options have a strike price of $0.10, vest at the end of the Board term on December 3, 2015 and expire December 3, 2017.  Year to date expense related to these options is $21,950 as of March 31, 2016.

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  Year to date expense related to these options is $4,240 as of March 31, 2016. 

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  Year to date expense related to these options is $4,401 as of March 31, 2016.

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal.  All other terms remain the same.  Year to date expense related to these options is $489 as of March 31, 2016.

As of March 31, 2016, there was $23,145 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period (December 2016) of the underlying option.

We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:

Risk free interest rate	1.077	%
Expected life	2.0 – 4.5	years
Expected volatility	167.37 – 113.50	%
Dividend yield	0.00	%

10

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 6 - STOCK OPTIONS AND WARRANTS, Continued

A summary of the status of our outstanding stock options as of March 31, 2016 and June 30, 2015 and changes during the periods then ended is presented below:

	March 31, 2016						June 30, 2015
			Weight Average		Intrinsic					Weight Average			Intrinsic
	Shares		Exercise Price		Value		Shares			Exercise Price			Value
Outstanding beginning of period		2,270,000	$	0.14				1,754,000		$	0.17
Granted		1,530,000	$	0.10				670,000		$	0.10
Expired/Cancelled		-	$	0.00				(154,000	)	$	(0.29	)
Exercised		-	$	0.00				-		$	0.00
Outstanding end of period		3,800,000	$	0.13	$	-		2,270,000		$	0.14		$	-
Exercisable		2,945,000	$	0.13	$	-		1,752,500		$	0.16		$	-

The intrinsic value of outstanding and exercisable shares is based on the closing price of the Company’s common stock of $0.07 per share on March 31, 2016 ($0.02 per share on June 30, 2015), the last trading day of the quarter.  In the event that the closing stock price is below an option exercise price the intrinsic value is $0.

The following table summarizes the range of outstanding and exercisable options as of March 31, 2016:

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at March 31, 2016		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at March 31, 2016		Weighted Average Remaining Contractual Life
$	0.08		150,000		5.67	$	0.08		150,000		5.67
$	0.10		2,200,000		3.09	$	0.10		1,345,000		3.09
$	0.17		1,450,000		4.67	$	0.17		1,450,000		4.67
			3,800,000						2,945,000

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of March 31, 2016 the warrants have not vested.

NOTE 7 - LIQUIDITY

The Company has been working during the past year to improve its liquidity and access to capital resources. In order to execute the strategic business plan discussed during our shareholder meeting in December 2015, the Company requires more capital resources. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company’s financial position and enhance shareholder value.

Over the past year, the Company has been able to secure extended credit terms and increased credit lines as a result of improved relationships with our vendors. We consider strong vendor relationships to be a critical success factor for our business going forward. We continue to focus on customer adherence to our established collection policies and proactive communication with our customers, including adjusting credit limits to allow for increased sales volume where warranted.

11

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

March 31, 2016

NOTE 7 - LIQUIDITY, Continued

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to those required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan.  We continue to work to reduce our overall costs wherever possible.

To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows. We continue discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

As of March 31, 2016, the Company has approximately 6,989,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

The Company has also instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters where appropriate to monetize inventory and improve our cash flow.

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended March 31, 2016, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.

NOTE 8 - SUBSEQUENT EVENTS

In April 2016, 150,000 shares that had vested at March 31, 2016 for the CEO and CFO were issued.

12

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. The historical results set forth in this discussion and analysis are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.

Overview

Amerityre engages in the research and development, manufacturing and sale of polyurethane tires.  We believe that we have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, including abrasion resistance, energy efficiency and load-bearing capabilities, when compared to conventional rubber tires.  We also believe that our manufacturing processes are more energy efficient than the traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. Using our polyurethane technologies, we believe tires can be produced which last longer, are less susceptible to failure and are friendly to the environment.  

We are concentrating on three segments of the tire market: closed-cell polyurethane foam tires, polyurethane elastomer forklift tires and agricultural tires. Our focus continues to be applications and markets where our advantages in product technology give us an opportunity to provide unique products and obtain premium pricing. Our most recent activities in these areas are set forth below:

Closed-Cell Polyurethane Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors and dealers accounts for the majority of our revenue. We have the ability to produce a broad range of products for the light duty tire market. Our efforts in product development and marketing allow us to continue to build customer relationships and expand sales with original equipment manufacturers and tire distributors.  We continue our focus on creating unique product solutions for customers with specific tire performance requirements.

Polyurethane Elastomer Forklift Tires – During the fourth quarter of FY 2016 we will relaunch the forklift tire product line. We are also developing new elastomer tire products for specific customer applications. We expect sales in this market segment to increase in the coming quarters as these new products are introduced and gain market acceptance. 

Agricultural Tires – Sales of agricultural tires continue to be negatively impacted by the dramatic downturn in farm commodity prices, which has in turn reduced farm income levels and available money for investment in farm equipment. Our experience is consistent with the reports provided by large agricultural equipment suppliers, several who have announced expectations for another challenging year in 2016 for farmer income and farm-related spending. Despite growing market acceptance of our pivot tire and seeder tire technologies, financial considerations have forced potential agricultural tire customers to delay purchases.  Given this backdrop, we are not anticipating dramatic agricultural sales gains for FY 2017 compared to FY 2016. We continue to pursue additional distribution relationships, both domestically and internationally, to increase our market penetration for our agricultural tires. We have found that the strength of the US Dollar versus other foreign currencies has negatively impacted our international business. We expect that exchange rate effects will continue to dampen our international sales efforts in the coming quarters.  

Due to the Company’s limited resources, tire projects which are contingent on additional significant development, such as composite and automotive tires, have been put on hold and will be revisited at a later date.

As described above, our product line covers diverse market segments which are unrelated in terms of customer base, product, distribution, market demands and competition. Our sales team is comprised of two independent manufacturer representatives whose experience is complementary to our product portfolio plus our in-house sales department.  The Company’s emphasis on proper product pricing and new marketing campaigns continues to drive more profitable sales, as shown by our profitable FY 2016 third quarter results.  We continue to have a solid backlog for orders to be delivered over the next 12 months.  However, we expect that the challenging economic environment, particularly in the agricultural market, will continue to provide strong headwinds and negatively impact our results.

At our Annual Meeting in December 2015, management outlined their action plan to improve results at Amerityre over the coming year. The lack of available capital resources has caused a delay in many of these initiatives, as all activities need to be financed out of internal cash flow. Despite this handicap, improvements in company performance are being made, and the Company will continue to explore and pursue all strategic options for financing, investment, and partnerships to obtain the capital necessary to finance the future strategic plans of the Company.

13

Factors Affecting Results of Operations

Our operating expenses consisted primarily of the following:

·   Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

·   Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

·   Research and development expenses, which consist primarily of contractor and direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

·   Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

·   Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

·   Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

Revenue Recognition

Revenue for products is recognized when the sales amount is determined, shipment of goods to the customer has occurred and collection is reasonably assured. Generally, we ship all of our products FOB origination.

Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at March 31, 2016, totaling $479,633 with accumulated amortization of $297,421 for a net book value of $182,212. Patent and trademark costs capitalized at June 30, 2015, $479,633 with accumulated amortization of $276,923 for a net book value of $202,710.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. Annually, pending or expired patents are inventoried and analyzed.  As of March 31, 2016 and 2015, respectively, there was no recognition of a loss on abandonment, expiration or retirement of patents and trademarks.

14

Amortization expense for the nine months ended March 31, 2016 and 2015 was $20,498and $24,040, respectively.  The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other.  We consider the following indicators, among others, when determining whether or not our patents are impaired:

·   any changes in the market relating to the patents that would decrease the life of the asset;

·   any adverse change in the extent or manner in which the patents are being used;

·   any significant adverse change in legal factors relating to the use of the patents;

·   current period operating or cash flow loss combined with our history of operating or cash flow losses;

·   future cash flow values based on the expectation of commercialization through licensing; and

·   current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

Inventory

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The cost of finished goods includes the cost of raw material, direct and indirect labor, and other indirect manufacturing costs. The inventory consists of chemicals, finished goods produced in the Company’s plant and products purchased for resale.

Financial and Derivative Instruments

The Company periodically enters into financial instruments. Upon entry, each instrument is reviewed for debt or equity treatment.  In the event that the debt or equity treatment is not readily apparent, FASB ASC 480-10-S99 is consulted for temporary treatment.  Once an event takes place that removes the temporary element the Company appropriately reclassifies the instrument to debt or equity. 

The Company periodically assesses its financial and equity instruments to determine if they require derivative accounting. Instruments which may potentially require derivative accounting are conversion features of debt, equity, and common stock equivalents in excess of available authorized common shares, and contracts with variable share settlements.  In the event of derivative treatment, we mark the instrument to market.

Stock-Based Compensation

We account for stock-based compensation under the provisions of Accounting Standards Codification 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended March 31, 2016 and 2015 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the nine months ended March 31, 2016 and 2015 was $ 56,238 and $18,638, respectively.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the quarters ended March 31, 2016 and 2015 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

15

Results of Operations

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:

·   Sales consisting of product sales;

·   Sales, net of returns and trade discounts, which is an indicator of our overall business growth and the success of our sales and marketing efforts;

·   Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

·   Growth in our customer base, which is an indicator of the success of our sales efforts; and

·   Distribution of sales across our products offered.

The following summary table presents a comparison of our results of operations for the three and nine months ended March 31, 2016 and 2015 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below. 

	For the Three Months Ended March 31,									For the Nine Months Ended March 31
	(in 000’s)						Change			(in 000’s)							Change
	2016			2015			2016 vs. 2015			2016				2015			2016 vs. 2015
Net revenues	$	936		$	1,191			(21.4	%)		$	2,865		$	3,572			(19.8	%)
Cost of revenues		(618	)		(852	)		(27.5	%)			(2,082	)		(2,689	)		(22.6	%)
Gross profit		318			339			(6.2	%)			783			883			(11.3	%)
Research  and development expenses		(57	)		(58	)		(1.7	%)			(166	)		(156	)		6.4	%
Sales and marketing expense		(54	)		(141	)		(61.7	%)			(220	)		(427	)		(48.5	%)
General and administrative expense		(172	)		(190	)		(9.5	%)			(667	)		(638	)		4.5	%
Other income (expense)		-			-				-			(2	)		-			0.0	%
Net income (loss)		35			(50	)		(170.0	%)			(272	)		(337	)		(19.3	%)
Preferred stock dividend		(25	)		(25	)		0.0	%			(75	)		(75	)		0.00	%
Net income (loss) attributable to common shareholders	$	10		$	(75	)		(113.3	%)		$	(347	)	$	(412	)		(15.8	%)

As disclosed in our June 30, 2015 Annual Report on Form 10-K, although our sales no longer show strong seasonality trends, our fiscal first quarter has traditionally been our weakest quarter and we again saw this trend in FY 2016.  During the recent quarter we experienced lower than expected sales in the agricultural tire market segments, as the expected rise in agricultural tire sales in the “pre-planting” season failed to materialize.  This is consistent with reports from other equipment and parts manufacturers, who noted a general softness in manufacturing activity and farm income last quarter.  We continue to expect strong headwinds in the agricultural market to negatively impact the sales of agricultural tires in the coming quarters. Our international sales continue to be negatively impacted by the US Dollar exchange rate versus foreign exchange rates. Over the past year, our products in foreign markets have increased in price by as much as 25% in local currency terms.

Three Months Ended March 31, 2016 Compared to March 31, 2015

Net Sales.  Net sales of $936,612 for the quarter ended March 31, 2016, represents a 21.4% decrease over net sales of $1,190,841 for the same period in 2015.  These results were not in line with our expectations as we anticipated that we would have stronger pivot tire sales for the period. Our sales were driven primarily by closed cell foam tire sales. We continue to have a positive response to our marketing and pricing plans for our polyurethane foam tires, which has helped to maintain our sales backlog level. Our forecast for the fiscal 2016 fourth quarter anticipates continued depressed agricultural tire sales, due to the continuation of depressed farm income as well as the seasonal shift of farmer focus on planting crops rather than purchasing equipment.

16

Cost of Revenues.  Cost of revenues for the quarter ended March 31, 2016 was $618,366 or 66.0% of sales compared to $851,688 or 71.5% of sales for the same period in 2015. Cost of revenues were lower due to decreases in raw materials cost and overhead costs (specifically lower depreciation expense and manufacturing supply cost) partially offset by higher repairs and maintenance including manufacturing equipment repairs, when compared to the prior period.  Starting July 1, 2015 the Company modified its customer freight policy, providing savings of approximately $32,000 for this three month period. The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs. 

Gross Profit.  Gross profit for the quarter ended March 31, 2016 was $318,246 compared to $339,153 for the same period in 2015. Gross profit for the quarter ended March 31, 2016 decreased by $20,907 or 6.2% over the same period in 2015 due to the decrease in revenue offset by the savings in cost of revenue outlined in the discussion above.  The March 31, 2016 gross profit reflects a 34.0% gross margin for product sales compared to a gross margin on product sales of 28.5% in 2015.

Research & Development Expenses (R&D).  Research and development expenses for the quarter ended March 31, 2016 were $56,839 compared to $58,146 for the same period in 2015. Research and development expenses decreased $1,307 between periods, resulting in a relatively flat period over period result, as we continue to focus on product formulation research and product testing, and maintain a part-time chemist on site.  The Company plans to continue this level of expenditure as R&D is a key component our business improvement initiatives.

Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended March 31, 2016 were $53,639 compared to $140,573 for the same period in 2015. Sales and marketing expenses decreased $86,934 or 61.8% between periods primarily due to lower travel costs, lower advertising expenses, a reduction in outside sales representatives (from 3 to 2), and the effect of the modifications to the 2015 sales commission program. All other expenses were generally consistent between periods.  

General & Administrative Expenses.  General and administrative expenses for the quarter ended March 31, 2016 were $172,270 compared to $189,936 for the same period in 2015. General and administrative expenses decreased $17,666 between periods primarily due to decreases in salaries, consulting and director travel expenses offset by increases in stock based compensation and professional fees.  All other expenses were generally consistent between periods.

Other Income/(Expense).  Other expense for the quarter ended March 31, 2016 was ($842) compared to other income $100 for the same period in 2015. In July 2015, the Company leased equipment resulting in $870 in interest expense for the quarter.  The Company had no interest expense in the same period in 2015.

Net Income.  Net income for the quarter ended March 31, 2016 of $34,656 represents a 170.0% decrease in net loss compared to the quarter ended March 31, 2015 loss of $49,402.  

Nine Months Ended March 31, 2016 Compared to March 31, 2015

Net Sales.  Net sales of $2,865,433 for the nine months ended March 31, 2016, represents a 19.8% decrease over net sales of $3,571,901 for the same period in 2015. These results were not in line with our expectations as we anticipated that we would have stronger pivot tire sales for the collective nine months. Our sales were driven primarily by closed cell foam tire sales in the mobility segment. We have also seen good response to our marketing and pricing plans for our polyurethane foam tires, which has helped to maintain our sales backlog level. Our sales forecast for the fiscal 2016 fourth quarter includes minimal agricultural tire sales, which we expect to continue to be negatively impacted by depressed farm income levels.

Cost of Revenues.  Cost of revenues for the nine months ended March 31, 2016 was $2,081,813 or 72.7% of sales compared to $2,688,553 or 75.3% of sales for the same period in 2015. Cost of revenues were lower due to decreases in raw materials cost and lower overhead costs (specifically lower depreciation expense, damages returns and plant wages) partially offset by higher repairs and maintenance including manufacturing equipment repairs, when compared to the prior period.  Starting July 1, 2015, the Company modified its customer freight policy, providing savings of approximately $71,000 for the period. The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs. 

Gross Profit.  Gross profit for the nine months ended March 31, 2016 was $783,620 compared to $883,348 for the same period in 2015. Gross profit for the period March 31, 2016 decreased by $99,728 or 11.3% over the same period in 2015 due to the decrease in revenue offset by the savings in cost of revenue outlined in the discussion above.  The March 31, 2016 gross profit reflects a 27.3% gross margin for product sales compared to a gross margin on product sales of 24.7% in 2015.

17

Research & Development Expenses (R&D).  Research and development expenses for the nine months ended March 31, 2016 were $166,406 compared to $155,636 for the same period in 2015. Research and development expenses increased $10,770 between periods due to a full 9 months of having a part-time chemist on site offset by salaries, as we continue to focus on product formulation research and product development.  The Company plans to continue this level of expenditure as R&D is a key component of the company business improvement initiatives.

Sales & Marketing Expenses. Sales and marketing expenses for the nine months ended March 31, 2016 were $219,898 compared to $426,778 for the same period in 2015. Sales and marketing expenses decreased $206,880 or 48.5% between periods primarily due to lower travel costs, fewer trade show expenses, a reduction in outside sales representatives (from 3 to 2), lower print advertising expense and the effect of the 2015 sales commission program. All other expenses were generally consistent between periods. 

General & Administrative Expenses.  General and administrative expenses for the nine months ended March 31, 2016 were $666,910 compared to $638,231 for the same period in 2015. General and administrative expenses increased $28,679 between periods primarily due to increases in salaries, stock based compensation, legal fees, and warranty expense offset by savings in consulting and professional expenses, and director travel expense.  All other expenses were generally consistent between periods.

Other Income/(Expense).  Other expense for the nine months ended March 31, 2016 was ($2,267) compared to other income $466 for the same period in 2015. In July 2015, the Company leased equipment resulting in $2,404 in interest expense for the nine months. The Company had no interest expense in the same period in 2015.

Net Loss.  Net loss for the nine months ended March 31, 2016 of $271,861 represents a 19.3% decrease in net loss for the nine months ended March 31, 2015 of $336,831.  

Liquidity and Capital Resources

Our principal sources of liquidity are of cash and payments received from our customers.  We do not have any significant credit arrangements.  Historically, our expenses have exceeded our sales, resulting in operating losses.  From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments.   Management continues to evaluate financing options but to date has chosen to delay financing at terms that will subject the Company to high costs of debt or will raise money through stock sales at what we believe are highly dilutive share prices.

We have historically not succeeded in establishing favorable short term financing but we continue to maintain a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.  As of March 31, 2016 we have not needed to activate this financing option due to increased focus on adherence to established collection policies and proactive communication with repeat customers, adjusting credit limits to allow for increased sales volume.

Cash Flows

The following table sets forth our cash flows for the nine months ended March 31, 2016 and 2015.

	Nine Months ended Mar. 31,
	(in 000’s)
	2016			2015
Net cash used by operating activities	$	(272	)	$	(325	)
Net cash used in investing activities		-			(46	)
Net cash used by financing activities		(80	)		(77	)
Net decrease in cash during the period	$	(352	)	$	(448	)

Net Cash Used by Operating Activities. Our primary sources of operating cash during the nine months ended March 31, 2016 came from collections from customers, however, our period end receivables balance increased as we waited for several large customers to remit payment in early April 2016. Our primary use of operating cash was an increase in prepaid and other current assets, specifically related to renewal of insurance policies.  Net cash used by operating activities was $272,473 for the nine months ended March 31, 2016 compared to net cash used by operating activities of $324,700 for the same period in 2015. 

18

Non-cash items include depreciation and amortization and stock based compensation.  Our net loss was $271,861 for the nine months ended March 31, 2016 compared to a net loss of $336,831 for the same period in 2015. The net loss for fiscal 2016 included non-cash expenses for depreciation and amortization of $116,338 and stock-based compensation (both stock issued and options) of $56,238.  As of March 31, 2015, depreciation and amortization was $146,930 and stock-based compensation (both stock issued and options) totaled $18,638.

Net Cash Used by Investing Activities.  Net cash used by investing activities was $0 for the nine months ended March 31, 2016 and $45,786 for the same period in 2015.  Although we did not purchase equipment as of March 31, 2016 we did lease equipment for research and development purposes.  

Net Cash Used by Financing Activities.  Net cash used by financing activities was $79,925 for the nine months ended March 31, 2016 and $77,272 for the same period in 2015. The primary use of cash for the period ended March 31, 2016 was payment toward the capital lease of $3,322, payment of notes payable of $1,603 and payment of preferred share dividend of $75,000.

Contractual Obligations and Commitments

The following table summarizes our contractual cash obligations and other commercial commitments at March 31, 2016.

	Payments due by period
	Total		Less than 1 year		1 to 3 years		3 to 5 years		After 5 years
Facility lease (1)	$	584,700	$	136,500	$	275,400	$	172,800	$	-
Capital lease for equipment		20,294		8,697		11,597		-		-
Preferred share dividend		425,000		100,000		200,000		125,000		-
Total contractual cash obligations	$	1,029,994	$	245,197	$	486,997	$	297,800	$	-

(1)   In May 2015, we negotiated a five (5) year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  All other terms and conditions of the building lease remain in effect.

Cash Position, Outstanding Indebtedness and Future Capital Requirements

At May 6, 2016, our total cash balance was $161,206 none of which is restricted; accounts receivables was $287,472; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $627,728. Our total indebtedness was $254,305 and includes $70,103 in accounts payable, $103,030 in accrued expenses, $11,767 in current portion of long-term debt, $15,565 in capital lease liability and $53,840 in long-term debt.

            We have been working during the past year to improve our liquidity and access to capital resources. In order to execute the strategic business plan discussed during our shareholder meeting in December 2015, we require more capital resources. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company’s financial position and enhance shareholder value.

Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing credit facility. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan.  We continue to work to reduce our overall costs wherever possible.

19

To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

Management continues to execute its strategic plan focusing on “Profitability as a Mindset”.  The Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. Improvement in results has continued and the Company has been successful in reducing its required breakeven sales level. The recent quarterly results saw record quarterly profit levels for the Company. We believe our program to establish “Profitability as a Mindset” is a success and we are committed to continuing these efforts. 

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended March 31, 2016, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.  However, to expand manufacturing and sales operations beyond the current level, additional capital may be required.

The Company has instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters to monetize inventory and improve our cash flow.

As of May 9, 2016, the Company has approximately 6,989,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

Off-Balance Sheet Arrangements

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.

20

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations.  We invest primarily in United States Treasury instruments with short-term (less than one year) maturities.  The carrying amount of these investments approximates fair value due to the short-term maturities.  Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.

ITEM 4. CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer, concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

21

PART II - OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2015.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.  OTHER INFORMATION

None.

ITEM 6.  EXHIBITS

31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 INS	XBRL Instance Document
101 SCH	XBRL Taxonomy Extension Schema Document
101 CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101 DEF	XBRL Taxonomy Extension Definition Linkbase Document
101 LAB	XBRL Taxonomy Extension Label Linkbase Document
101 PRE	XBRL Taxonomy Extension Presentation Linkbase Document

22

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:  May 10, 2016

AMERITYRE CORPORATION
By:
/s/ Michael F. Sullivan	/s/ Lynda R. Keeton-Cardno
Michael F. Sullivan Chief Executive Officer (Principal Executive Officer)	Lynda R. Keeton-Cardno Chief Financial Officer (Principal Financial and Accounting Officer)

23

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael F. Sullivan, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three and nine months ended March 31, 2016;

2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and I have:

(a)           designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d)           disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.           I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)           all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)           any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2016

/s/ Michael F. Sullivan              

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the "Company") on Form 10-Q for the three and nine months ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael F. Sullivan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002, that, to the best of my knowledge and belief:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Michael F. Sullivan                  

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

May 10, 2016

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lynda R. Keeton-Cardno, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three and nine months ended March 31, 2016;

2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and I have:

(a)           designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)           designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)           presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d)           disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.           I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)           all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)           any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2016

/s/ Lynda R. Keeton-Cardno                  

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the "Company") on Form 10-Q for the three and nine months ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lynda R. Keeton-Cardno, Chief  Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley  Act of 2002, that, to the best of my knowledge and belief:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Lynda R. Keeton-Cardno                  

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial Officer)

May 10, 2016

XML

Document And Entity Information - shares	9 Months Ended
	Mar. 31, 2016	May. 09, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Amerityre Corp
Document Type	10-Q
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		42,175,287
Amendment Flag	false
Entity Central Index Key	0000945828
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3

XML

Balance Sheets - USD ($)	Mar. 31, 2016	Jun. 30, 2015
CURRENT ASSETS
Cash	$ 103,319	$ 455,717
Accounts receivable - net	486,264	314,054
Accounts receivable - related party	0	6,312
Inventory - net	634,991	661,129
Prepaid and other current assets	66,199	27,860
Total Current Assets	1,290,773	1,465,072
PROPERTY AND EQUIPMENT
Leasehold improvements	153,543	153,543
Molds and models	577,549	572,894
Equipment	2,960,246	2,937,922
Furniture and fixtures	74,921	74,921
Software	305,924	305,924
Less - accumulated depreciation	(3,831,584)	(3,735,744)
Total Property and Equipment	240,599	309,460
OTHER ASSETS
Patents and trademarks - net	182,212	202,710
Non-current inventory	187,380	186,560
Deposits	11,000	11,000
Total Other Assets	380,592	400,270
TOTAL ASSETS	1,911,964	2,174,802
CURRENT LIABILITIES
Accounts payable and accrued expenses	452,052	438,680
Current portion of long-term debt	12,005	13,608
Current portion of lease liability	5,938	0
Total Current Liabilities	469,995	452,288
Long-term debt	53,840	53,840
Long-term lease liability	10,077	0
Total Long-Term Liabilities	63,917	53,840
TOTAL LIABILITIES	533,912	506,128
STOCKHOLDERS' EQUITY
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively	2,000	2,000
Common stock: 75,000,000 shares authorized of $0.001 par value, 42,025,287 and 41,441,620 shares Issued and outstanding, respectively	42,025	41,570
Additional paid-in capital	62,567,140	62,515,856
Stock payable	4,500	0
Accumulated deficit	(61,237,613)	(60,890,752)
Total Stockholders' Equity	1,378,052	1,668,674
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,911,964	$ 2,174,802

XML

Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2016	Jun. 30, 2015
Preferred stock par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	2,000,000	2,000,000
Preferred stock, shares outstanding	2,000,000	2,000,000
Common stock par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	42,025,287	41,441,620
Common stock, shares outstanding	42,025,287	41,441,620

XML

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
NET SALES	$ 936,612	$ 1,190,841	$ 2,865,433	$ 3,571,901
COST OF GOODS SOLD	618,366	851,688	2,081,813	2,688,553
GROSS PROFIT	318,246	339,153	783,620	883,348
EXPENSES
Research and development	56,839	58,146	166,406	155,636
Sales and marketing	53,639	140,573	219,898	426,778
General and administrative	172,270	189,936	666,910	638,231
Total Expenses	282,748	388,655	1,053,214	1,220,645
INCOME (LOSS) FROM OPERATIONS	35,498	(49,502)	(269,594)	(337,297)
OTHER (EXPENSE)/INCOME
Interest expense	(870)	0	(2,404)	0
Interest income	28	100	137	466
Total Other (Expense)/Income	(842)	100	(2,267)	466
NET INCOME (LOSS)	34,656	(49,402)	(271,861)	(336,831)
Preferred Stock Dividend	(25,000)	(25,000)	(75,000)	(75,000)
NET INCOME (LOSS)ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ 9,656	$ (74,402)	$ (346,861)	$ (411,831)
BASIC INCOME (LOSS)PER SHARE (in Dollars per share)	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares)	41,951,935	41,524,135	41,770,978	41,469,326
DILUTED INCOME (LOSS)PER SHARE (in Dollars per share)	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares)	41,951,935	41,524,135	41,770,978	41,469,326

XML

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (271,861)	$ (336,831)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization expense	116,338	146,930
Change in allowance for bad debt recovery	(289)	(8,066)
Stock paid for services	0	5,147
Stock based compensation related to consultant, employee and director options	56,238	18,638
Changes in operating assets and liabilities:
Accounts receivable	(165,609)	(121,652)
Inventory and inventory reserve	25,318	156,426
Prepaid and other current assets	(38,339)	(81,906)
Accounts payable and accrued expenses	5,731	(103,385)
Net Cash Used by Operating Activities	(272,473)	(324,699)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	0	(45,786)
Net Cash Used by Investing Activities	0	(45,786)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments on lease liability	(3,322)	0
Payments on notes payable	(1,603)	(2,084)
Preferred stock issuance costs	0	(188)
Preferred stock dividends	(75,000)	(75,000)
Net Cash Used by Financing Activities	(79,925)	(77,272)
NET DECREASE IN CASH	(352,398)	(447,757)
CASH AT BEGINNING OF PERIOD	455,717	728,585
CASH AT END OF PERIOD	103,319	280,828
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES
Interest paid	2,404	0
Income taxes paid	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Capitalized lease	19,337	0
Reclassification of accounts receivable – related party to accounts receivable	6,312	0
Equipment purchase accrued for, not paid in cash	7,641	0
Reversal of deferred financing costs	$ 0	$ 31,500

XML

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

9 Months Ended

Mar. 31, 2016

Disclosure Text Block [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K.  Operating results for the nine months ended March 31, 2016 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.

XML

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2015 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at March 31, 2015.

Trade Receivables

We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses. As of March 31, 2016 and 2015, the reserve for uncollectible accounts was $-0- and $7,556, respectively.

Stock Based-Compensation Expense

We account for stock-based compensation under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended March 31, 2015 and 2016 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the nine months ended March 31, 2016 and 2015 was $56,238 and $18,638, respectively.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the nine months ended March 31, 2016 and 2015 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation, except for the three months ended March 31, 2016.  For the three months ended March 31, 2016 only warrants and options “in the money” have been included in the dilutive calculation, which resulted in zero additional weighted average shares.  We excluded 4,300,000 and 2,924,000 common stock equivalents for the nine months ended March 31, 2016 and 2015, respectively, because they are anti-dilutive.

Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities’ processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.

In February 2016, the FASB issued ASU No. 2016-02, "Leases", ("ASU 2016-02") which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2018 with early adoption permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on the Company's financial statements.

In March 2016, the FASB issued ASU No. 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." ASU 2016-09 amends several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period. The Company is currently evaluating the impact of the adoption of ASU 2016-09 on the Company's financial statements.

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board (IASB) to improve financial reporting by creating common revenue recognition guidance for GAAP and International Financial Reporting Standards (IFRS).  In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.” ASU 2016-10 clarifies the implementation guidance on identifying performance obligations. These ASUs apply to all companies that enter into contracts with customers to transfer goods or services. These ASUs are effective for public entities for interim and annual reporting periods beginning after December 15, 2017. Early adoption is permitted, but not before interim and annual reporting periods beginning after December 15, 2016. Entities have the choice to apply these ASUs either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying these standards at the date of initial application and not adjusting comparative information. The Company is currently evaluating the impact of the adoption of ASU 2016-10 on the Company's financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

Related Party Transactions

Amerityre’s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  As of December 2015, with Mr. Ryan’s exit from our Board of Directors, he was no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.

We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.  In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.  Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced from our Boulder City location.

XML

NOTE 3 - INVENTORY

9 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

	March 31, 2016			June 30, 2015
	(Unaudited)
Raw Materials	$	307,388		$	302,910
Finished Goods		631,780			655,714
Inventory reserve		(116,797	)		(110,935	)
Inventory - net	$	822,371			847,689

Our inventory reserve reflects items that were deemed to be slow moving or obsolete based on an analysis of all inventories on hand.

The Company critically reviews all slow moving inventory to determine if defective or obsolete.  If not defective or obsolete, but slow moving, we present these items as non-current inventory, although all inventory is ready and available for sale at any moment. 

XML

NOTE 4 - CAPITAL LEASE

9 Months Ended

Mar. 31, 2016

Disclosure Text Block Supplement [Abstract]

Debt and Capital Leases Disclosures [Text Block]

NOTE 4 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2016:

2016	$	2,188
2017		8,697
2018		8,697
2019		725
2020		-
Total minimum lease payments		20,307
Less:  executory costs		-
Net minimum lease payments		20,307
Less:  amount representing interest		4,292
Present value of net minimum payments	$	16,015

XML

NOTE 5 - STOCK TRANSACTIONS

9 Months Ended

Mar. 31, 2016

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

NOTE 5 - STOCK TRANSACTIONS

As of March 31, 2016, the Board of Directors granted the following stock bonus awards:

·   To all non-officer employees of Amerityre on record as of July 22, 2015, a one-time stock bonus award of 5,000 shares of the Company’s restricted common stock per employee, valued at $0.015 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).  As of July 22, 2015 there were 16 non-officer employees at Amerityre resulting in 80,000 shares, which were issued in July 2015.

·   To the officers of Amerityre, 600,000 shares were granted on July 20, 2015 (valued at $0.03) with 75% of the grant allocated to the CEO and 25% of the grant allocated to the CFO.  The shares of stock vest ratably each quarter end during fiscal year 2016 and are payable immediately after the vesting date.  For the nine months ended March 31, 2016 the Company recognized $13,500 of compensation expense for these grants; $4,500 of which is a stock payable.

·   In February 2016,the Board approved 75,000 shares of stock be issued to a senior management employee in connection with his employment agreement, valued at $0.025 a share (fair value on the date of grant with a 50% discount pursuant to U.S. Internal Revenue Service, revenue Ruling 77-287).  These shares were issued in March 2016.

XML

NOTE 6 - STOCK OPTIONS AND WARRANTS

9 Months Ended

Mar. 31, 2016

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-based Payments [Text Block]

NOTE 6 - STOCK OPTIONS AND WARRANTS

General Option Information

On July 6, 2011, the Board of Directors cancelled the “2004 Non-Employee Directors’ Stock Incentive Plan” and approved the "Directors’ 2011 Stock Option and Award Plan”.   Under the 2011 Plan, a total of 3,300,000 shares are authorized for issuance.

The Company also maintained the 2005 Stock Option and Award Plan, which was previously approved by shareholders, for the purpose of granting option awards to its employees and consultants.   This plan had a 10 year life and expired July 2015.

On August 10, 2015, the Board of Directors cancelled the “Directors’ 2011 Stock Option and Award Plan” as all options under this plan had been granted and adopted the “2015 Omnibus Stock Option and Award Plan” which contains provisions for up to 3,000,000 stock options to be granted to employees, consultants and directors.  The 2015 Omnibus Stock Option and Award Plan did not obtain the necessary shareholder approval in the Company’s annual proxy process, resulting in certain U.S. Internal Revenue Service provisions to be ineffective.

Option issuances and vesting during the nine month period ending March 31, 2016

On December 1, 2014, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2015 and expire December 1, 2020.  Year to date expense related to these options is $7,746 as of March 31, 2016. 

On January 21, 2015, 50,000 options were granted to the Company’s Chief Financial Officer as part of her employment offer.  The options have a strike price of $0.10, vest ratably January 21, 2015 to December 1, 2015 and expire December 1, 2018.  Year to date expense related to these options is $840 as of March 31, 2016.

In the October 2015 Board meeting, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the fiscal year ended June 30, 2015.  The options have a strike price of $0.10, vest at the end of the Board term on December 3, 2015 and expire December 3, 2017.  Year to date expense related to these options is $21,950 as of March 31, 2016.

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.  Year to date expense related to these options is $4,240 as of March 31, 2016. 

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016.  The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.  Year to date expense related to these options is $4,401 as of March 31, 2016.

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement.  The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019.  In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal.  All other terms remain the same.  Year to date expense related to these options is $489 as of March 31, 2016.

As of March 31, 2016, there was $23,145 of unrecognized stock-based compensation expense related to stock options that will be recognized over the vest period (December 2016) of the underlying option.

We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:

Risk free interest rate	1.077	%
Expected life	2.0 – 4.5	years
Expected volatility	167.37 – 113.50	%
Dividend yield	0.00	%

A summary of the status of our outstanding stock options as of March 31, 2016 and June 30, 2015 and changes during the periods then ended is presented below:

	March 31, 2016						June 30, 2015
			Weight Average		Intrinsic					Weight Average			Intrinsic
	Shares		Exercise Price		Value		Shares			Exercise Price			Value
Outstanding beginning of period		2,270,000	$	0.14				1,754,000		$	0.17
Granted		1,530,000	$	0.10				670,000		$	0.10
Expired/Cancelled		-	$	0.00				(154,000	)	$	(0.29	)
Exercised		-	$	0.00				-		$	0.00
Outstanding end of period		3,800,000	$	0.13	$	-		2,270,000		$	0.14		$	-
Exercisable		2,945,000	$	0.13	$	-		1,752,500		$	0.16		$	-

The intrinsic value of outstanding and exercisable shares is based on the closing price of the Company’s common stock of $0.07 per share on March 31, 2016 ($0.02 per share on June 30, 2015), the last trading day of the quarter.  In the event that the closing stock price is below an option exercise price the intrinsic value is $0.

The following table summarizes the range of outstanding and exercisable options as of March 31, 2016:

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at March 31, 2016		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at March 31, 2016		Weighted Average Remaining Contractual Life
$	0.08		150,000		5.67	$	0.08		150,000		5.67
$	0.10		2,200,000		3.09	$	0.10		1,345,000		3.09
$	0.17		1,450,000		4.67	$	0.17		1,450,000		4.67
			3,800,000						2,945,000

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2015.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of March 31, 2016 the warrants have not vested.

XML

NOTE 7 - LIQUIDITY

9 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Substantial Doubt about Going Concern [Text Block]

NOTE 7 - LIQUIDITY

The Company has been working during the past year to improve its liquidity and access to capital resources. In order to execute the strategic business plan discussed during our shareholder meeting in December 2015, the Company requires more capital resources. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company’s financial position and enhance shareholder value.

Over the past year, the Company has been able to secure extended credit terms and increased credit lines as a result of improved relationships with our vendors. We consider strong vendor relationships to be a critical success factor for our business going forward. We continue to focus on customer adherence to our established collection policies and proactive communication with our customers, including adjusting credit limits to allow for increased sales volume where warranted.

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to those required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan.  We continue to work to reduce our overall costs wherever possible.

To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows. We continue discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

As of March 31, 2016, the Company has approximately 6,989,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

The Company has also instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be utilized in the upcoming quarters where appropriate to monetize inventory and improve our cash flow.

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended March 31, 2016, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.

XML

NOTE 8 - SUBSEQUENT EVENTS

9 Months Ended

Mar. 31, 2016

Subsequent Events [Abstract]

Subsequent Events [Text Block]

NOTE 8 - SUBSEQUENT EVENTS

In April 2016, 150,000 shares that had vested at March 31, 2016 for the CEO and CFO were issued.

XML

Accounting Policies, by Policy (Policies)

9 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Reclassification, Policy [Policy Text Block]

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements, specifically the recognition of the preferred share dividend as a non-cash transaction at March 31, 2015.

Trade and Other Accounts Receivable, Policy [Policy Text Block]

Trade Receivables

We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses. As of March 31, 2016 and 2015, the reserve for uncollectible accounts was $-0- and $7,556, respectively.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Stock Based-Compensation Expense

We account for stock-based compensation under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended March 31, 2015 and 2016 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the nine months ended March 31, 2016 and 2015 was $56,238 and $18,638, respectively.

ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the nine months ended March 31, 2016 and 2015 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

Earnings Per Share, Policy [Policy Text Block]

Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation, except for the three months ended March 31, 2016.  For the three months ended March 31, 2016 only warrants and options “in the money” have been included in the dilutive calculation, which resulted in zero additional weighted average shares.  We excluded 4,300,000 and 2,924,000 common stock equivalents for the nine months ended March 31, 2016 and 2015, respectively, because they are anti-dilutive.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” requiring all deferred tax assets and liabilities, and any related valuation allowance, to be classified as noncurrent on the balance sheet. The classification change for all deferred taxes as noncurrent simplifies entities’ processes as it eliminates the need to separately identify the net current and net noncurrent deferred tax asset or liability in each jurisdiction and allocate valuation allowances. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”. Under ASU 2015-11, inventory will be measured at the “lower of cost and net realizable value” and options that currently exist for “market value” will be eliminated. The standard defines net realizable value as the “estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” No other changes were made to the current guidance on inventory measurement. ASU 2015-11 is effective for interim and annual periods beginning after December 15, 2016. Early application is permitted and should be applied prospectively. The Company is currently evaluating the impact the adoption of ASU 2015-11 will have on its financial statements.

In February 2016, the FASB issued ASU No. 2016-02, "Leases", ("ASU 2016-02") which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2018 with early adoption permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on the Company's financial statements.

In March 2016, the FASB issued ASU No. 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." ASU 2016-09 amends several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period. The Company is currently evaluating the impact of the adoption of ASU 2016-09 on the Company's financial statements.

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 completes the joint effort by the FASB and International Accounting Standards Board (IASB) to improve financial reporting by creating common revenue recognition guidance for GAAP and International Financial Reporting Standards (IFRS).  In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing.” ASU 2016-10 clarifies the implementation guidance on identifying performance obligations. These ASUs apply to all companies that enter into contracts with customers to transfer goods or services. These ASUs are effective for public entities for interim and annual reporting periods beginning after December 15, 2017. Early adoption is permitted, but not before interim and annual reporting periods beginning after December 15, 2016. Entities have the choice to apply these ASUs either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying these standards at the date of initial application and not adjusting comparative information. The Company is currently evaluating the impact of the adoption of ASU 2016-10 on the Company's financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

Related Party Transactions Policy [Policy Text Block]

Related Party Transactions

Amerityre’s immediate past Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  As of December 2015, with Mr. Ryan’s exit from our Board of Directors, he was no longer a director of the Company and all receivables outstanding to Rhino Rubber LLC have been reflected as trade accounts receivable.

We currently distribute directly from our manufacturing facility in Boulder City, Nevada only.  In the past we also distributed from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  The Company paid $600 for monthly warehousing fees inclusive of freight, shipping and labor for mounting services through October 31, 2015.  Effective October 31, 2015 we closed the Akron, Ohio distribution point and customers are serviced from our Boulder City location.

XML

NOTE 3 - INVENTORY (Tables)

9 Months Ended

Mar. 31, 2016

Inventory Disclosure [Abstract]

Schedule of Inventory [Table Text Block]

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value. The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

	March 31, 2016			June 30, 2015
	(Unaudited)
Raw Materials	$	307,388		$	302,910
Finished Goods		631,780			655,714
Inventory reserve		(116,797	)		(110,935	)
Inventory - net	$	822,371			847,689

XML

NOTE 4 - CAPITAL LEASE (Tables)

9 Months Ended

Mar. 31, 2016

Disclosure Text Block Supplement [Abstract]

Schedule of Capital Leased Assets [Table Text Block]

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of March 31, 2016:

2016	$	2,188
2017		8,697
2018		8,697
2019		725
2020		-
Total minimum lease payments		20,307
Less:  executory costs		-
Net minimum lease payments		20,307
Less:  amount representing interest		4,292
Present value of net minimum payments	$	16,015

XML

NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)

9 Months Ended

Mar. 31, 2016

Disclosure Text Block Supplement [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:

Risk free interest rate	1.077	%
Expected life	2.0 – 4.5	years
Expected volatility	167.37 – 113.50	%
Dividend yield	0.00	%

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the status of our outstanding stock options as of March 31, 2016 and June 30, 2015 and changes during the periods then ended is presented below:

	March 31, 2016						June 30, 2015
			Weight Average		Intrinsic					Weight Average			Intrinsic
	Shares		Exercise Price		Value		Shares			Exercise Price			Value
Outstanding beginning of period		2,270,000	$	0.14				1,754,000		$	0.17
Granted		1,530,000	$	0.10				670,000		$	0.10
Expired/Cancelled		-	$	0.00				(154,000	)	$	(0.29	)
Exercised		-	$	0.00				-		$	0.00
Outstanding end of period		3,800,000	$	0.13	$	-		2,270,000		$	0.14		$	-
Exercisable		2,945,000	$	0.13	$	-		1,752,500		$	0.16		$	-

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The following table summarizes the range of outstanding and exercisable options as of March 31, 2016:

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at March 31, 2016		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at March 31, 2016		Weighted Average Remaining Contractual Life
$	0.08		150,000		5.67	$	0.08		150,000		5.67
$	0.10		2,200,000		3.09	$	0.10		1,345,000		3.09
$	0.17		1,450,000		4.67	$	0.17		1,450,000		4.67
			3,800,000						2,945,000

XML

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Allowance for Doubtful Accounts Receivable	$ 0	$ 7,556
Share-based Compensation	$ 56,238	$ 18,638
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	4,300,000	2,924,000
Affiliated Entity [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Costs and Expenses, Related Party	$ 600

XML

NOTE 3 - INVENTORY (Details) - Schedule of Inventory - USD ($)	Mar. 31, 2016	Jun. 30, 2015
Schedule of Inventory [Abstract]
Raw Materials	$ 307,388	$ 302,910
Finished Goods	631,780	655,714
Inventory reserve	(116,797)	(110,935)
Inventory - net	$ 822,371	$ 847,689

XML

NOTE 4 - CAPITAL LEASE (Details) - USD ($)	Mar. 31, 2016	Jul. 31, 2015
Disclosure Text Block Supplement [Abstract]
Capital Leases, Future Minimum Payments Due	$ 20,307	$ 19,337

XML

NOTE 4 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets - USD ($)	Mar. 31, 2016	Jul. 31, 2015
Schedule of Capital Leased Assets [Abstract]
2016	$ 2,188
2017	8,697
2018	8,697
2019	725
2020	0
Total minimum lease payments	20,307	$ 19,337
Less: executory costs	0
Net minimum lease payments	20,307
Less: amount representing interest	4,292
Present value of net minimum payments	$ 16,015

XML

NOTE 5 - STOCK TRANSACTIONS (Details) - USD ($)			1 Months Ended	9 Months Ended
	Jul. 22, 2015	Jul. 20, 2015	Feb. 29, 2016	Mar. 31, 2016	Mar. 31, 2015
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Gross	80,000	600,000	75,000
Shares Issued, Price Per Share (in Dollars per share)	$ 0.015	$ 0.03	$ 0.025
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date	50.00%
Share-based Compensation (in Dollars)				$ 56,238	$ 18,638
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award			fair value on the date of grant with a 50% discount
Each Employee [Member]
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Gross	5,000
Chief Executive Officer [Member]
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]
Grant Allocation		75.00%
Chief Financial Officer [Member]
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]
Grant Allocation		25.00%
CEO and CFO [Member]
NOTE 5 - STOCK TRANSACTIONS (Details) [Line Items]
Share-based Compensation (in Dollars)				13,500
Stock Payable (in Dollars)				$ 4,500

XML

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - USD ($)						1 Months Ended		9 Months Ended	12 Months Ended
	Jan. 19, 2016	Dec. 01, 2015	Jan. 21, 2015	Dec. 01, 2014	Jul. 06, 2011	Oct. 31, 2015	Sep. 30, 2013	Mar. 31, 2016	Jun. 30, 2015	Aug. 10, 2015
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross								1,530,000	670,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options								$ 23,145
Share Price								$ 0.07	$ 0.02
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value								$ 0	$ 0
Directors' 2011 Stock Option and Award Plan [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized					3,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period					10 years
2015 Omnibus Stock Option and Award Plan [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized										3,000,000
Convertible Debt [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share Price							$ 0.25
Convertible Notes Payable, Current							$ 100,000
Class of Warrant or Rights, Granted							500,000
Debt Issuance Cost							$ 6,500
Warrants, Term of Warrants							3 years
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.13
Chief Executive Officer [Member] | Options Granted December 1, 2014 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				480,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price				$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date				Dec. 01, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date				Dec. 01, 2020
Allocated Share-based Compensation Expense								7,746
Chief Executive Officer [Member] | Options Granted December 1, 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		480,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price		$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date		Dec. 01, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date		Dec. 01, 2020
Allocated Share-based Compensation Expense								4,240
Chief Financial Officer [Member] | Options Granted January 21, 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			50,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price			$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date			Dec. 01, 2018
Allocated Share-based Compensation Expense								840
Chief Financial Officer [Member] | Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	50,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price	$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 01, 2019
Allocated Share-based Compensation Expense								489
Monthly Health Insurance Reimbursement	$ 550
Board member [Member] | Options Granted October 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						100,000
Board member [Member] | Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	100,000
Audit Committee Chair [Member] | Options Granted October 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						50,000
Audit Committee Chair [Member] | Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	50,000
Board Members and Audito Committe Chair [Member] | Options Granted October 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price						$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date						Dec. 03, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date						Dec. 03, 2017
Allocated Share-based Compensation Expense								21,950
Board Members and Audito Committe Chair [Member] | Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price	$ 0.10
Allocated Share-based Compensation Expense								$ 4,401
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date	December 2016
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	December 2019
Minimum [Member] | Chief Financial Officer [Member] | Options Granted January 21, 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date			Jan. 21, 2015
Minimum [Member] | Chief Financial Officer [Member] | Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date	Jan. 21, 2016
Maximum [Member] | Chief Financial Officer [Member] | Options Granted January 21, 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date			Dec. 01, 2015
Maximum [Member] | Chief Financial Officer [Member] | Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date	Dec. 01, 2016

XML

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions	9 Months Ended
	Mar. 31, 2016
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions [Line Items]
Risk free interest rate	1.077%
Dividend yield	0.00%
Minimum [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions [Line Items]
Expected life	2 years
Expected volatility	167.37%
Maximum [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Valuation Assumptions [Line Items]
Expected life	4 years 6 months
Expected volatility	113.50%

XML

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($)	9 Months Ended	12 Months Ended
	Mar. 31, 2016	Jun. 30, 2015
Schedule of Share-based Compensation, Stock Options, Activity [Abstract]
Outstanding beginning of period	2,270,000	1,754,000
Outstanding beginning of period	$ 0.14	$ 0.17
Granted	1,530,000	670,000
Granted	$ 0.10	$ 0.10
Expired/Cancelled	0	(154,000)
Expired/Cancelled	$ (0.00)	$ (0.29)
Exercised	0	0
Exercised	$ 0.00	$ 0.00
Outstanding end of period	3,800,000	2,270,000
Outstanding end of period	$ 0.13	$ 0.14
Outstanding end of period	$ 0	$ 0
Exercisable	2,945,000	1,752,500
Exercisable	$ 0.13	$ 0.16
Exercisable	$ 0	$ 0

XML

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range - $ / shares	9 Months Ended
	Mar. 31, 2016	Jun. 30, 2015	Jun. 30, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options Outstanding	3,800,000	2,270,000	1,754,000
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.13	$ 0.14	$ 0.17
Number of Exercisable Options	2,945,000	1,752,500
Options at $0.08 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price of Options (in Dollars per share)	$ 0.08
Number of Options Outstanding	150,000
Weighted Average Remaining Contractual Life of Outstanding Options	5 years 244 days
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.08
Number of Exercisable Options	150,000
Weighted Average Remaining Contractual Life of Exercisable Options	5 years 244 days
Options at $0.10 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price of Options (in Dollars per share)	$ 0.10
Number of Options Outstanding	2,200,000
Weighted Average Remaining Contractual Life of Outstanding Options	3 years 32 days
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.10
Number of Exercisable Options	1,345,000
Weighted Average Remaining Contractual Life of Exercisable Options	3 years 32 days
Options at $0.17 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price of Options (in Dollars per share)	$ 0.17
Number of Options Outstanding	1,450,000
Weighted Average Remaining Contractual Life of Outstanding Options	4 years 244 days
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.17
Number of Exercisable Options	1,450,000
Weighted Average Remaining Contractual Life of Exercisable Options	4 years 244 days

XML

NOTE 7 - LIQUIDITY (Details)	9 Months Ended
	Mar. 31, 2016 shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Shares Available for Issuance	6,989,000

XML

NOTE 8 - SUBSEQUENT EVENTS (Details)	1 Months Ended
	Apr. 30, 2016 shares
CEO and CFO [Member] | Subsequent Event [Member]
NOTE 8 - SUBSEQUENT EVENTS (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures	150,000